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Objective: To investigate correlates of polypharmacy at discharge from wards of general
medicine and geriatrics.
Population: 2465 patients enrolled in the Gruppo Italiano di Farmacovigilanza nell’Anziano
(GIFA) study.
Main outcome measure: Polypharmacy, ie having more than 6 drugs prescribed at discharge.
Methods: Data on drugs prescribed at home, during hospital stay, and at discharge were collected
according to a validated procedure. Logistic regression analysis was used to identify independent
correlates of polypharmacy at discharge. The adherence to current therapeutic guidelines was
assessed for selected drugs (digitalis, diuretics, antithrombotics, bronchodilators)
Results: The median number of prescribed drugs was 3.0 before admission and 4.0 at discharge
(p < 0.001). Polypharmacy prior to admission (Odds Ratio [OR] 4.32, 95% Confidence Interval
[CI] 3.13–5.96), cumulative comorbidity (OR 1.81, 95% CI 1.40–2.32) and selected chronic
conditions (diabetes, heart failure, chronic obstructive pulmonary disease, renal insufficiency,
and depression) were significant correlates of polypharmacy at discharge. Negative correlate of
the outcome was the occurrence of adverse drug reactions prior to admission (OR 0.22, 95% CI
0.09–0.51). The rate of appropriate prescription reached 80% only for antithrombotics either at
home or in hospital and at discharge.
Conclusions: Hospitalization increases drug prescription at discharge in elderly patients. Efforts
are needed to identify the determinants and to assess the quality of this prescription practice,
with the final aim of contrasting polypharmacy.
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Introduction
Elderly people are the greatest consumers of drugs in western countries: the number of
daily used drugs rises from 2.0 ± 1.9 for people aged 65–74 years to 2.5 ± 2.0 for
people aged 75 and over (Chen et al 2001). Polypathology, a strictly age-correlated
phenomenon, is likely to be the main determinant of drug consumption. However, both
over-prescribing and improper prescribing has been reported and seems to contribute
to the age-related increase in the prevalence of adverse drug reactions (ADRs) (Onder,
Pedone, et al 2002; Chang et al 2005). On average, ADRs account for 3%–13% of all
the admissions (Atkin and Shenfield 1995; Mannesse et al 2000; Onder, Pedone, et al
2002; Pirmohamed et al 2004) and complicate 5%–20% of the stays of patients over 65
years (Onder, Gambassi, et al 2002; Somers et al 2003; Corsonello et al 2005). Thus,
any effort should be made to limit and to rationalize drug prescription. Pursuing such
an objective requires that physicians be aware of the dynamics at the basis of
polypharmacy in the current clinical practice. In this perspective, it should be clarified
whether the hospitalization moderates or promotes drug utilization. Finally, the
appropriateness of drug prescription should be also assessed besides quantifying drug
use. The present study has been undertaken to assess both correlates of polypharmacy,
as estimated on discharge prescriptions from wards of general medicine and geriatrics,Therapeutics and Clinical Risk Management 2007: 3(1) 198
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and appropriate prescription. A further objective was to
investigate the effects of hospitalization on the number of
prescribed drugs in the whole population studied and in groups
identified by the most prevalent diseases.
Methods
Patients
The present study uses data from a large observational study
group, the Gruppo Italiano di Farmacovigilanza nell’Anziano
(GIFA), a collaborative group based in community and
university hospitals located throughout Italy. GIFA
periodically surveyed drug consumption, occurrence of
ADRs, and quality of hospital care from 1988 to 1998. We
used data on patients consecutively admitted to the 24
participating geriatric or internal medicine wards during the
4-month survey carried out in 1998. We did not use data
collected in previous years to minimize the differences in
actual prescribing practice. Methods of the GIFA have been
previously described (Carosella et al 1999). Briefly, a study
physician with specific training completed a questionnaire
for each patient at admission to hospital and updated it daily.
Data recorded included sociodemographic characteristics,
medical variables, complete blood count, neuropsychological
and physical function variables.
Overall, 3010 patients were enrolled in the survey period.
We excluded patients who died during hospital stay (n = 117)
and those with missing data for any of the variables of interest
(n = 428, including people with cognitive deficit severe
enough to make the completion of geriatric assessment
impossible), with a final sample of 2465 patients (839 patients
<65 years; 1035 patients 65–79 years; 591 patients 80 years
or more). Patients who died during their stay differed from
that included in the analysis for a greater prevalence of older
age (80 years or more: 57.3% vs 24.0%, p < 0.001), congestive
heart failure (CHF) (29.1% vs 16.1%, p < 0.001), and renal
failure (15.4% vs 6.9%, p < 0.01). The use of more than 3
drugs prior to admission was similar in both included and
excluded patients (63.7% and 63.5%, respectively).
The outcome of the study was having more than 6 drugs
prescribed at discharge from the acute care hospital, where 6
corresponds to the 75th percentile of the number of prescribed
drugs distribution. Information on pharmacological therapy
prior to the hospitalization was collected by asking patients
or their relatives to provide all drug samples and their
respective prescriptions. This procedure was made according
to a previously validated method (Carosella et al 1999). Drugs
were coded by Anatomical and Therapeutical Classification
(ATC) (Pahor et al 1994).
Variables specifically considered in this study were age,
gender, and type of ward. The presence of depressive
symptoms was ascertained using the 15-item Geriatric
Depression Scale (GDS), and patients with a GDS score
greater than 5 were considered as depressed (Lesher and
Berryhill 1994). Functional and cognitive capabilities were
measured by Basic and Instrumental Activities of Daily Living
(BADL and IADL) scale (Katz et al 1963), and Hodgkinson
Abbreviated Mental Test (AMT) (Jitapunkul et al 1991),
respectively. Patients having an AMT score of 7 or less were
considered cognitively impaired (Rocca et al 1992). Diagnoses
were coded according to International Classification of
Diseases, Clinical Modification 9th revision (ICD-9 CM)
(WHO 1980). Having more than 4 diagnoses was considered
as an index of cumulative comorbidity. Furthermore, highly
prevalent age-related chronic conditions that may increase
the consumption of drugs (hypertension, diabetes mellitus,
congestive heart failure, coronary artery disease, cerebral
vascular disease, peripheral vascular disease, chronic
obstructive pulmonary disease (COPD), chronic renal failure,
hepatic insufficiency, and malignancies) were also considered
as potential correlates. The number of drugs taken in the 30
days before hospital admission was also considered in the
analysis, and information on drug therapy in people with
cognitive impairment was collected by caregivers.
Finally, the occurrence of ADRs before admission and
during hospital stay were also considered as potential
correlates of the outcomes. The study researcher evaluated
the participants daily and screened for any new event that
could possibly be due to an ADR. For every such event, a
dedicated section of the study questionnaire was completed,
including the description of the ADR, the suspected drug(s),
the severity of the ADR ranging from mild to life-threatening,
and an algorithm that provided a graded probability of cause-
effect relationship between the suspected drug(s) and the ADR
(Naranjo et al 1981).
Procedures conformed to guidelines provided by the
Catholic University Ethical Committee.
Statistical analysis
We used contingency tables to compare the demographic and
clinical characteristics of patients grouped according to
whether they had less than 7, or more than 6 drugs prescribed
at discharge. We then built multivariable logistic regression
model to evaluate the individual association withTherapeutics and Clinical Risk Management 2007: 3(1) 199
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polypharmacy of the characteristics whose prevalence was
different between the two groups. Since the presence of
depressive symptoms has been previously reported to increase
the number of prescribed drugs (Antonelli Incalzi et al 2005),
the analysis was also repeated after excluding anxiolytic and
antidepressant drugs from the definition of polypharmacy.
In this secondary analysis we excluded also anxiolytics
because of the high prevalence of anxious symptoms in elderly
depressed patients (Lenze et al 2001).
The effects of hospitalization on the number of prescribed
drugs in the whole population studied and in groups identified
by the most prevalent mean diseases were also investigated
by comparing the number of drugs taken before admission
and prescribed at discharge. Wilcoxon’s signed rank test was
used in this analysis because data were not normally
distributed.
To verify whether inappropriate prescribing could
contribute to increase the number of prescribed drugs at
discharge, we also investigated the prevalence of selected
clinical conditions in patients having digoxin, diuretics,
antithrombotics, or inhaled bronchodilators prescribed before
admission, during stay or at discharge. The indications we
considered in the analysis were heart failure or atrial
fibrillation for digoxin; heart failure, hypertension, and renal
or hepatic insufficiency for diuretics; atrial fibrillation,
congestive heart failure, coronary artery disease, peripheral
or cerebral vascular disease for antithrombotics; COPD or
asthma for inhaled bronchodilators. Finally, to distinguish the
impact of drugs presumably prescribed for a brief period to
complete a short term course from that of drugs generally
prescribed for long-term therapies on polypharmacy at
discharge, we assessed the prevalence of prescription of
antibiotics or steroids and that of antihypertensive or
hypoglycemic agents. All analyses were performed using
SPSS V10.0 (SPSS Inc., Chicago, IL, USA).
Results
Of the 2465 patients considered in the analysis, 532 (21.6%)
had reduced, 517 (21.0%) had unchanged, and 1,416 (57.4%)
had increased number of drugs at discharge with respect to
the month prior to admission. The number of patients already
taking more than 6 drugs before admission was 172 (7.0%).
The outcome was present in 489 (19.8%) patients.
Demographic and clinical characteristics of patients
divided according to the number of drugs prescribed at
discharge from the acute care hospital are shown in Table 1.
Patients having more than 6 drugs prescribed were slightly
older and more frequently female than patients having less
than 7 drugs prescribed. Having more than 4 diagnoses was
more frequent among those taking more drugs, as were the
diagnoses of congestive heart failure, coronary artery disease,
hypertension, diabetes mellitus, peripheral vascular disease,
COPD, and renal insufficiency. Physical dependency and
depressive symptoms, but not cognitive impairment, were
more prevalent among patients having 7 or more drugs
prescribed at discharge. A history of ADRs prior to admission
was negatively correlated with a discharge prescription of
over 6 drugs, whereas in hospital ADRs qualified as a positive
correlate. Finally, the greater the number of drugs taken at
home, the greater the number of drugs prescribed at discharge.
Table 1 Demographic and clinical characteristics of patients
divided according to the number of drugs prescribed at
discharge
Number of drugs at discharge
≤ ≤ ≤ ≤ ≤6 (n = 1976) % >6 (n = 489) % p
Age <0.001
<65 36.3 24.7
65–79 40.6 47.6
≥80 23.1 27.6
Gender (Male) 57.5 52.8 0.056
Type of ward 0.112
Geriatric 65.7 69.5
Medicine 34.3 30.5
No of diagnoses >4 40.5 69.9 <0.001
Congestive heart failure 12.3 31.7 <0.001
Coronary artery disease 28.0 40.1 <0.001
Hypertension 36.9 45.6 <0.001
Diabetes Mellitus 15.2 36.6 <0.001
Cerebral vascular 13.6 14.3 0.665
disease
Peripheral vascular 4.3 7.4 0.004
disease
Chronic obstructive 9.6 19.4 <0.001
pulmonary disease
Renal insufficiency 4.9 14.9 <0.001
Hepatic insufficiency 7.1 7.4 0.547
Malignancies 6.5 7.2 0.617
Dependency in at least 7.6 14.1 <0.001
1 BADL
Dependency in at least 33.1 52.1 <0.001
1 IADL
Cognitive impairment 19.2 17.0 0.253
Depression 25.9 42.1 <0.001
ADRs before admission 3.8 1.6 0.016
ADRs during stay 10.0 13.7 0.017
No of drugs before 57.4 89.4 <0.001
admission>3
Abbreviations: ADRs, adverse drug reactions; BADL, basic activities of daily
living; IADL, instrumental activities of daily living.Therapeutics and Clinical Risk Management 2007: 3(1) 200
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Multivariable logistic regression model showed that age
per se was not significantly associated with the outcome.
Polypharmacy prior to admission, cumulative comorbidity,
diabetes mellitus, congestive heart failure, COPD, and renal
insufficiency were significant correlates of the number of
prescribed drugs at discharge. Depressive symptoms also were
a significant independent correlate of the outcome, while the
occurrence of ADRs prior to admission was the only negative
correlate (Table 2). Depressive symptoms remained
significantly associated with the outcome also after excluding
antidepressant and anxiolytic agents from the computation
of the number of prescribed drugs (OR = 1.47; 95% CI =
1.18–2.01).
In patients treated with digoxin, the prevalence of
recognized indications ranged from 58.4% (at home) to 65.1%
(discharge prescription). In patients treated with diuretics,
antithrombotics, or inhaled bronchodilators, the
corresponding figures were 66.8%, 79.5%, and 69.1% before
admission, and 71.9%, 80.5%, and 69.3% at discharge,
respectively (Figure 1).
Finally, the use of antibiotics or systemic steroids, ie, drugs
which are likely to be prescribed for a brief period to complete
a short term course, rose from 4.2% and 4.2% before
admission to 8.9% and 6.0% at discharge, respectively.
However, the use of drugs prescribed to treat a chronic
condition, such as antihypertensives, also increased from
59.0% prior to admission to 66.9% at discharge (Figure 2).
Table 2 Summary logistic regression model of selected
variables to having more than 6 drugs prescribed at discharge
OR 95% CI
Age
<65 1.0
65–79 0.97 0.73–1.28
≥80 0.87 0.63–1.21
Gender (Males) 0.81 0.64–1.02
No of diagnoses>4 1.81 1.40–2.32
Congestive heart failure 2.05 1.57–2.68
Coronary artery disease 1.24 0.97–1.58
Hypertension 1.05 0.83–1.32
Diabetes Mellitus 2.65 2.07–3.41
Peripheral vascular disease 1.36 0.86–2.14
Chronic obstructive pulmonary disease 2.09 1.53–2.85
Renal insufficiency 1.88 1.29–3.03
Dependency in at least 1 BADL 1.33 0.92–1.93
Dependency in at least 1 IADL 1.19 0.93–1.52
Depressive symptoms 1.67 1.32–2.12
ADRs before admission 0.22 0.09–0.51
ADRs during stay 1.41 0.97–2.08
No of drugs before admission>3 4.32 3.13–5.96
Abbreviations: ADRs, adverse drug reactions; BADL, basic activities of daily
living; IADL, instrumental activities of daily living.
Figure 1 Prevalence of correct indications in patients having digoxin (atrial fibrillation or congestive heart failure), diuretics (hypertension, congestive heart failure,
renal or hepatic insufficiency), antithrombotics (atrial fibrillation, congestive heart failure, coronary artery disease, peripheral or cerebral vascular disease, pulmonary
embolism or thrombophlebitis) or inhaled bronchodilators (chronic obstructive pulmonary disease, asthma or rinhitis) prescribed at home, during hospital stay, and at
discharge, respectively.Therapeutics and Clinical Risk Management 2007: 3(1) 201
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Discussion
The present study shows that age per se does not carry a higher
risk of polypharmacy, while age-related polypathology does.
Similar results have been previously obtained: comorbid
conditions, such as diabetes and chronic lung disease, but not
older age, predict a greater complexity and cost of drugs
regimen in elderly patients with heart failure (Masoudi et al
2005). Our study also shows that the appropriateness of the
prescription is frequently questionable and the hospitalization
results in a considerable increase in drug prescription (with
regard to previous home therapy). These findings confirm the
high prevalence of inappropriate prescribing observed in
previous reports from the GIFA study (Onder et al 2003, 2005).
The link between polypathology and polypharmacy is an
obvious one, mainly for diseases such as diabetes mellitus or
COPD, posing several therapeutic problems which are partly
secondary to a variety of complications. However, the lack
of a reliable explanation to the use of selected drugs, at least
on the basis of current therapeutic guidelines, suggests that
over-prescription is a common problem in elderly population.
Indeed, there is evidence that diuretics are frequently
prescribed to treat edema secondary to venous stasis or chronic
respiratory failure (Van Kraij et al 1998; Kelly and Chamber
2000), whereas physical measures and the correction of blood
gas derangement should be the respective therapeutic
approach (ATS 1995; Kwon et al 2003). Furthermore, both
leg edema and COPD have been associated with undue
digitalis use (Aronow 1996; Antonelli Incalzi et al 2001).
Symptoms such as dyspnea and asthenia, have also been
reported to justify the use of digitalis in the absence of a well
defined pathogenetic interpretation (Haas and Young 1999).
Thus, both over prescription and undue prescription seem to
characterize the overall pharmacological therapy of the elderly.
Depressive symptoms are significantly associated with
polypharmacy even after having excluded antidepressants and
anxiolytics from the computation. This finding replicates
results by Simons and colleagues (1992) and Antonelli Incalzi
and colleagues (2005), but it is of special concern in an elderly
population, which is exposed to a greater risk of ADRs. While
the complaint of disparate symptoms likely underlies this
association, a lack of attention to the elderly patient might
contribute to it. Indeed, general practitioners have been
reported to spend 12.4 and 11.2 minutes for visiting an adult
(45–64 years old) and an elderly (75 or older) patient,
respectively (Radecki et al 1988). Depression is highly
prevalent in the elderly (Stek et al 2004), mainly in women,
and, thus, physicians should be aware of the problem and
spend more time for depressed patients in order to clarify the
determinants of depressive symptoms and, thus, reassure the
patient and suggest nonpharmacologic measures. For
example, insomnia, one of the most common complaints of
depressed subjects, frequently resolves with behavioral
measures (McCall 2005).
ADRs before admission, but not in hospital ADRs, were
negatively correlated with a discharge prescription of over 6
drugs. Although it is possible that ADRs occurring during
stay may be due to the addition of new drugs need for the
acute condition causing hospitalization, physicians should
take into account their personal experience as a guide to the
prescription at discharge. Indeed, while selected drugs are
plagued by a higher incidence of ADRs, polypharmacy is the
main risk factors for ADRs (Hajjar et al 2003). Thus, attempts
should be made to curtail inappropriate drug prescription.
Unfortunately, such an attempt was made only for patients
with a history of ADRs at home.
Surprisingly, internists and geriatricians had a comparable
prescription practice. Theoretically, geriatricians should be
more aware of problems related to polypharmacy. Present
findings are in contrast with such an expectation and are not
likely to be confounded by differences in age, comorbidity
and functional status between patients admitted to medicine
and geriatrics wards. However, the increase in the number of
prescribed drugs at discharge could reflect, on average, an
increased need in both geriatrics and internal medicine wards.
Limitations for this study deserve consideration. First,
using data from 1998, results can not be inferred to the actual
Figure 2 Use of antibiotics or systemic steroids (upper panel), and of
antihypertensive or hypoglycemic agents (lower panel), before admission, during
hospital stay, and at discharge.Therapeutics and Clinical Risk Management 2007: 3(1) 202
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prescribing practice. However, the trend towards increased
polypharmacy since 1998 have continued on account of
evidence based medicine, and potential pitfalls of complex
drug regimens in patients with multiple chronic conditions
have been recently underlined (Tinetti et al 2004; Boyd et al
2005). New diagnoses made during the stay might justify the
increased drug prescription at discharge with regard to
previous home therapy. Furthermore, it is possible that patients
were not managed properly at home, thus causing their
hospital admissions with the resultant addition of drugs to
properly manage their diseases. We did not exclude people
already taking 6 or more drugs at admission. This choice might
have led to an overestimate of the prevalence of polypharmacy
at discharge. We decided to leave these patients in our analyses
because we could not assume that all of them would have
been discharged with 6 or more prescription; furthermore
the potential discrepancy is of only about 5%. Finally, some
drugs might have been prescribed for a brief period to
complete a short-term course. We could not correct our
analysis for these potential confounders. However, the fact
that most of newly prescribed drugs were devoted to treat
chronic conditions suggests that the hospitalization resulted
in a true and stable increase in drug use. This conclusion is
further strengthened by the evidence that drug prescription
at discharge increased for all the main disease categories.
In conclusion, a trend is evident towards increasing drug
prescription to the elderly discharged from general medicine
and geriatrics wards. While we cannot clarify the mechanisms
underlying this phenomenon, the risks related to polypharmacy
in the elderly will never be sufficiently emphasized. Then,
interventions should be promoted to identify the determinants
and to assess the quality of this prescription practice.
Furthermore, the general practitioner, who ultimately decides
which therapy her/his patient will follow, should critically
evaluate the discharge prescription and, if needed, discuss it
Table 3 Effects of hospitalization on the number of prescribed drugs in the whole population studied and in the most frequent
disease groups
        Number of drugs
Median (interquartile range)
Before admission At discharge Z p
All patients (n = 2456) 3.0 (2.0–5.0) 4.0 (3.0–6.0) –20.6 <0.001
CHF (n = 398) 5.0 (3.0–6.0) 6.0 (5.0–8.0) –10.8 <0.001
NIDDM (N = 480) 4.0 (2.0–6.0) 5.5 (4.0–7.0) –10.4 <0.001
COPD (N = 285) 4.0 (2.0–5.0) 5.0 (4.0–7.0) –8.8 <0.001
CRF (N = 169) 5.0 (3.0–6.5) 6.0 (4.0–8.0) –5.9 <0.001
Abbreviations: COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; CRF, chronic renal failure; NIDDM, noninsulin dependent diabetes
mellitus.
with the hospital physician. Finally, while evidence-based
guidelines are continuously produced to improve the treatment
of more and more diseases, guidelines should also be
implemented to provide the operational framework of the
approach to the elderly and frail patient.
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